Last reviewed · How we verify

NCT06561282

Predictive Role of Glucose/Potassium Ratio on Mortality in Major Burns.

Completed Last updated 21 August 2024
What this trial tests

trial in Burns in 200 participants. Completed in 1 July 2024.

Timeline
1 May 2022
Primary endpoint
1 May 2024
1 July 2024

Quick facts

Lead sponsorKonya Meram State Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date1 May 2022
Primary completion1 May 2024
Estimated completion1 July 2024
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Konya Meram State Hospital

Who can join

Eligibility, any sex, with Burns or Burn Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this observational study is to investigate the role of the glucose-potassium ratio in predicting mortality in patients with major burn trauma. The main question it aims to answer is: Can the glucose-potassium ratio predict mortality in major burn patients? The glucose-to-potassium ratios of major burn patients at the time of initial hospitalization will be determined, and their relationship with mortality will be analyzed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Burns

Currently open trials in the same condition.

Other Konya Meram State Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06561282.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing